Centre for Advanced Proteomic and Chemogenomic Analyses

Principal Investigator: Pierre Thibault, Michael Tyers
Theme : Science and Technology Platform
Competition : Genomics Technology Platforms: Operations Support and Technology Development Funds
Status : Completed
Start : Apr. 1, 2017
End: Mar. 31, 2022
Budget : $2,100,000.00

The Centre for Advanced Proteomic and Chemogenomic Analyses (CAPCA) provides leading-edge analyses to projects in cell biology, immunology, drug discovery and human health research. Since 2011, more than 270 research groups from academia, government and private laboratories in Canada and internationally have benefited from these services. Over the next five years, CAPCA will expand the breath of its services to include cutting-edge chemoproteomics and genome-scale analytical methods not currently available in Canada. In particular it will use new gene editing technology to implement a new chemogenomic service by directly assessing chemical/genetic interactions in human cells. CAPCA will bring value to the Canadian genomics network with leading-edge proteomic and chemogenomic analyses to meet unmet pressing needs in drug discovery programs.


Genome Centre: Génome Québec

Host Institution: Université de Montréal